Abstract
2016 Background: MGMT gene promoter methylation in tumor tissue of gliomas is now recognized as a predictive biomarker for response to temozolomide. Up to date there is lack of studies investigatin...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
